1. ACT-20 PHASE 1/2, PROSPECTIVE, INTERNATIONAL MULTI-CENTER STUDY TO ESTABLISH THE SAFETY AND FEASIBILITY OF BLOOD-BRAIN-BARRIER DISRUPTION COMBINED WITH CARBOPLATIN FOR RECURRENT GLIOBLASTOMA; FIRST CLINICAL EXPERIENCE IN JAPAN. (3rd December 2022) Authors: Kijima, Noriyuki; Kanemoto, Manabu; Oshino, Satoru; Tani, Naoki; Hosomi, Koichi; Okita, Yoshiko; Hirayama, Ryuichi; Tachi, Tetsuro; Kuroda, Hideki; Utsuki, Rena; Kagawa, Naoki; Kishima, Haruhiko Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗